| Autor: |
Pierlorenzi, Claudio, Nunzi, Marco, Cirulli, Sabino, Direnzo, Giovanni Francesco Maria, Curatella, Lucia, Liberatori, Sandra, Pascucci, Annalisa, Petrone, Edoardo, Ventre, Generoso, Varango, Concettina, Pulito, Maria Luisa, Varango, Antonella, Dandolo, Cosimo, Occupati, Brunella, Marenzi, Roberta, Leonardi, Claudio |
| Předmět: |
|
| Zdroj: |
Journal of Medical Case Reports; 4/6/2024, Vol. 18 Issue 1, p1-15, 15p |
| Abstrakt: |
Background: Considering the enormous burden represented by the opioid use disorder (OUD), it is important to always consider, when implementing opioid agonist therapy (OAT), the potential impact on patient's adherence, quality of life, and detoxification. Thus, the purpose of the study is to evaluate how the introduction of a novel OAT approach influences these key factors in the management of OUD. Case presentation: This article marks the pioneering use of OAT through buprenorphine implant in Europe and delves into the experience of six patients diagnosed with OUD at a relatively young age. The patients, comprising both males and a female, are of Caucasian Italian and African Italian ancestry (case 4) and exhibit an age range from 23 to 63, with an average drug abuse history of 19 ± 12 years. All patients were on stable traditional OAT before transitioning to buprenorphine implants. Despite the heterogeneity in social and educational backgrounds, health status, and drug abuse initiation histories, the case series reveals consistent positive treatment outcomes such as detoxification, absence of withdrawal symptoms and of side effects. Notably, all patients reported experiencing a newfound sense of freedom and improved quality of life. Conclusions: These results emphasise the promising impact of OAT via buprenorphine implants in enhancing the well-being and quality of life in the context of OUD. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
